<10           : 50 mg/kg then dose according to levels. Dose of 0.5–1 g daily is usually adequate
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Dialysed. Give 50 mg/kg daily in 4 divided doses. Monitor levels
HD                     :Dialysed. Dose as in GFR
<10           : mL/min, given post dialysis. Monitor trough level pre dialysis, and reduce post-dialysis dose accordingly
HDF/high flux   :Dialysed. Dose as in GFR
<10           : mL/min, given post dialysis. Monitor trough level pre dialysis, and reduce post-dialysis dose accordingly
CAV/VVHD      :Dialysed. Give dose as in GFR 10 to 20 mL/min and monitor blood levels, pre dose
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugsCytarabine: concentration of flucytosine possibly reduced
ADMINISTRATION
Reconstition
–
Route
IV peripherally through a blood filter
Rate of Administration
20–40 minutes
Comments
–
OTHER INFORMATION
Monitor blood levels 24 hours after therapy commences. Pre-dose level 25–50 mg/L is usually adequate. Do not exceed 80 mg/L250 mL intravenous flucytosine infusion contains 34.5 mmol sodiumBone marrow suppression more common in patients with renal impairmentTablets available on named patient basis onlyCan be given IP at a dose of 50 mg/L